In the media: Genomeweb: Partial reimbursement for comprehensive DNA test in the Netherlands

This week, Genomeweb’s Precision Oncology News brought the news that the Dutch House of Representatives has recently unanimously decided to reimburse the comprehensive DNA testing for certain patient groups.

Read the article.

More information about the comprehensive DNA test.

You read an article in the category Billing code. You may also be interested in OncoAct.
All news

Also read

Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

Actionable metastatic cancer genome is remarkably stable over time, despite treatment with drugs

10-08-2021

A one-time analysis of the entire tumor DNA is almost always sufficient to find all DNA errors that may be …

Single WGS analysis of metastases is sufficient in most cases

Single WGS analysis of metastases is sufficient in most cases

26-10-2021

DNA analysis of the tumor is of crucial importance to determine treatment options for patients with metastasized lung cancer. But …

Take a virtual tour of our laboratory: from the biopsy to the patient report

Take a virtual tour of our laboratory: from the biopsy to the patient report

26-01-2021

What happens to your tumor tissue and blood during a comprehensive DNA test? What exactly does all the complex equipment …

Would you like to be kept up to date with new developments?

Sign up for our newsletters

Want to know more about the complete DNA test?

Visit OncoAct.nl